Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 72) on a novel pancarcinoma antigen (TAG-72)
- PMID: 2429934
- DOI: 10.1002/ijc.2910380508
Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 72) on a novel pancarcinoma antigen (TAG-72)
Abstract
CA 72 is a monoclonal antibody (MAb) -defined antigenic determinant expressed on a pancarcinoma antigen (TAG-72) found in more than 85% of human colorectal carcinomas. An immunoradiometric assay has been developed using the murine MAb B72.3 to quantitate CA 72 in human serum. In a simultaneous immunoradiometric assay, the mean CA 72 concentration in 1,099 serum samples from healthy blood donors was 1.83 +/- 2.03 (SD) units/ml. If the upper limit of normal was set at 10 mu/mol of serum, a value including 99% of healthy blood donors, only 4 of 101 serum samples (4%) from patients with benign disease were elevated, whereas 15 of 26 (58%) and 14 of 25 (56%) of rectal and colon carcinoma patient sera, respectively, were positive. Serum samples from 84 benign colorectal disease cases were examined; of these, 0 of 28 (0%) colorectal adenoma, 1 of 39 (3%) ulcerative proctocolitis, 0 of 15 (0%) diverticulosis, and 0 of 2 (0%) irritable bowel disease sera contained more than 10 mu/ml CA 72. At a reference value of 20 mu/ml, 0 of 101 (0%) benign disease and 2 of 1,060 (0.2%) blood donor sera had elevated values, whereas 10 of 26 (38%) and 9 of 25 (36%) rectal and colon patient sera, respectively, remained positive. The majority of patients with pancreatic and ovarian cancer, and a significant fraction of stomach cancer patient sera, also contained elevated levels of CA 72. The ability of this assay to discriminate between malignant and benign diseases suggests its further evaluation for monitoring and diagnosis in groups at risk for development of cancer.
Similar articles
-
Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 125) associated with human epithelial ovarian carcinomas.Cancer Res. 1984 Mar;44(3):1048-53. Cancer Res. 1984. PMID: 6198078
-
Initial clinical evaluation of an immunoradiometric assay for CA 19-9 using the NCI serum bank.Int J Cancer. 1984 Mar 15;33(3):339-45. doi: 10.1002/ijc.2910330310. Int J Cancer. 1984. PMID: 6199316
-
A radioimmunoassay for the detection of a human tumor-associated glycoprotein (TAG-72) using monoclonal antibody B72.3.Int J Cancer. 1986 May 15;37(5):659-66. doi: 10.1002/ijc.2910370504. Int J Cancer. 1986. PMID: 3699929
-
In vivo and in vitro clinical applications of monoclonal antibodies against TAG-72.Int J Rad Appl Instrum B. 1991;18(4):395-401. doi: 10.1016/0883-2897(91)90066-t. Int J Rad Appl Instrum B. 1991. PMID: 1864728 Review.
-
Clinical usefulness of three monoclonal antibody-defined tumor markers: CA 19-9, CA 50, and CA 125.Tumour Biol. 1986;7(5-6):333-42. Tumour Biol. 1986. PMID: 2437641 Review.
Cited by
-
Serum levels of tumour associated glycoprotein (TAG 72) in patients with gynaecological malignancies.Br J Cancer. 1990 Jul;62(1):147-51. doi: 10.1038/bjc.1990.248. Br J Cancer. 1990. PMID: 2167724 Free PMC article.
-
The effect of circulating antigen and radiolabel stability on the biodistribution of an indium labelled antibody.Br J Cancer. 1991 Nov;64(5):850-6. doi: 10.1038/bjc.1991.412. Br J Cancer. 1991. PMID: 1931605 Free PMC article.
-
Unusually high serum CA19.9 in gastric carcinoma: A case report.Indian J Clin Biochem. 2008 Jan;23(1):100-2. doi: 10.1007/s12291-008-0025-3. Epub 2008 Mar 6. Indian J Clin Biochem. 2008. PMID: 23105733 Free PMC article.
-
Current status of tumor markers in large bowel cancer.World J Surg. 1989 Jan-Feb;13(1):52-9. doi: 10.1007/BF01671154. World J Surg. 1989. PMID: 2658354 Review.
-
Monoclonal antibody to a human pancreatic carcinoma cell line recognizes gastrointestinal neoplasms.Am J Pathol. 1989 Mar;134(3):641-9. Am J Pathol. 1989. PMID: 2466406 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials